How can imaging be used to guide treatment of breast cancer?
Authors: Rita Nanda, MD; Jessica W. T. Leung, MD, FACR, FSBI; John Lewin, MD, FACR, FSBI
Credits Available
Format: | On-line Lecture / Course |
RT Credit: | 1.00 ARRT Category A |
Physicians |
Target Audience and Goal Statement
This activity is intended for radiologists, oncologists, advanced practice practitioners (physician assistants, nurse practitioners), and radiologic technologists.
The goal of this activity is for learners to be better able to effectively collaborate with the multidisciplinary team to inform and optimize treatment of patients with breast cancer.
Learning Objectives
Upon completion of this activity, participants will:
Have increased knowledge regarding the
Demonstrate greater confidence in their ability to
Accreditation and Credit
This activity has been approved by the American Society of Radiologic Technologists (ASRT) for 1.00 hours of ARRT Category A continuing education credit.
How To Enroll and Participate
For physician credit you must enroll and participate at Medscape Education.
For other credit:
Faculty
Moderator:
Rita Nanda, MD
Associate Professor of Medicine
Director, Breast Oncology Program
The University of Chicago
Chicago, Illinois
Speakers:
Jessica W. T. Leung, MD, FACR, FSBI
Professor of Diagnostic Radiology
Deputy Chair, Department of Breast Imaging
The University of Texas
MD Anderson Cancer Center
Houston, Texas
John Lewin, MD
Associate Professor of Radiology and Biomedical Imaging
Division Chief, Breast Imaging
Yale School of Medicine
New Haven, Connecticut
Questions?
For questions regarding this program, please contact ICPME.
Email: information@icpmed.com
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.